Sequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Docetaxel|DRUG: Epirubicin|DRUG: Cyclophosphamide|DRUG: 5-fluoruracil|DRUG: Granulocyte-colony stimulating growth factor
Sponsor: Hellenic Oncology Research Group
Collaborators: University Hospital of Crete